Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast cancer

Bookmark and Share
Published: 23 Jan 2020
Views: 899
Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras

Dr Gerardo Umanzor speaks to ecancer at the 2019 San Antonio Breast Cancer Symposium about his trial involving oral paclitaxel with encequidar for metastatic breast cancer.

After outlining the study methods and results, Dr Umanzor outlines the benefits and limitations of this work, as well as his future plans for the study.

Watch his press conference here

Read more about the study here